Experience of treating pediatric hepatoblastoma at King Faisal Specialist Hospital and Research Center, Riyadh, Saudi Arabia – Timely surgical intervention playing a key role

Tanaka, 2013, International pediatric liver cancer pathological classification: current trend, Int J Clin Oncol, 18, 946, 10.1007/s10147-013-0624-8 Exelby, 1975, Liver tumors in children in the particular reference to hepatoblastoma and hepatocellular carcinoma: American Academy of Pediatrics Surgical Section Survey--1974, J Pediatr Surg, 10, 329, 10.1016/0022-3468(75)90095-0 Katzenstein, 2002, Treatment of unresectable and metastatic hepatoblastoma: a pediatric oncology group phase II study, J Clin Oncol, 20, 3438, 10.1200/JCO.2002.07.400 Perilongo, 2004, Risk-adapted treatment for childhood hepatoblastoma. final report of the second study of the International Society of Paediatric Oncology--SIOPEL 2, Eur J Canc, 40, 411, 10.1016/j.ejca.2003.06.003 Haas, 1989, Histopathology and prognosis in childhood hepatoblastoma and hepatocarcinoma, Cancer, 64, 1082, 10.1002/1097-0142(19890901)64:5<1082::AID-CNCR2820640520>3.0.CO;2-G Haas, 2001, Small cell undifferentiated histology in hepatoblastoma may be unfavorable, Cancer, 92, 3130, 10.1002/1097-0142(20011215)92:12<3130::AID-CNCR10115>3.0.CO;2-# Ortega, 2000, Randomized comparison of cisplatin/vincristine/fluorouracil and cisplatin/continuous infusion doxorubicin for treatment of pediatric hepatoblastoma: a report from the Children’s Cancer Group and the Pediatric Oncology Group, J Clin Oncol, 18, 2665, 10.1200/JCO.2000.18.14.2665 Fuchs, 2002, Pretreatment prognostic factors and treatment results in children with hepatoblastoma: a report from the German Cooperative Pediatric Liver Tumor Study HB 94, Cancer, 95, 172, 10.1002/cncr.10632 Perilongo, 2000, Liver tumour study group of the international society of paediatric O. SIOPEL trials using preoperative chemotherapy in hepatoblastoma, Lancet Oncol, 1, 94, 10.1016/S1470-2045(00)00018-8 Pritchard, 2000, Cisplatin, doxorubicin, and delayed surgery for childhood hepatoblastoma: a successful approach--results of the first prospective study of the International Society of Pediatric Oncology, J Clin Oncol, 18, 3819, 10.1200/JCO.2000.18.22.3819 Douglass, 1985, Effective cisplatin (DDP) based chemotherapy in the treatment of hepatoblastoma, Med Pediatr Oncol, 13, 187, 10.1002/mpo.2950130405 Black, 1991, Marked response to preoperative high-dose cis-platinum in children with unresectable hepatoblastoma, J Pediatr Surg, 26, 1070, 10.1016/0022-3468(91)90676-K Zhang, 2013, Clinical efficacy and prognosis factors for advanced hepatoblastoma in children: a 6-year retrospective study, Asian Pac J Cancer Prev APJCP, 14, 4583, 10.7314/APJCP.2013.14.8.4583 Watanabe, 2013, Current chemotherapeutic approaches for hepatoblastoma, Int J Clin Oncol, 18, 955, 10.1007/s10147-013-0616-8 Nishimura, 2002, High-dose chemotherapy in children with metastatic hepatoblastoma, Pediatr Int, 44, 300, 10.1046/j.1442-200X.2002.01549.x Perilongo, 2000, Hepatoblastoma presenting with lung metastases: treatment results of the first cooperative, prospective study of the International Society of Paediatric Oncology on childhood liver tumors, Cancer, 89, 1845, 10.1002/1097-0142(20001015)89:8<1845::AID-CNCR27>3.0.CO;2-D D’Antiga, 2007, Features predicting unresectability in hepatoblastoma, Cancer, 110, 1050, 10.1002/cncr.22876 Finegold, 2008, Liver tumors: pediatric population, Liver Transplant, 14, 1545, 10.1002/lt.21654 Zsiros, 2005, G. Initial low alphafoetoprotein level predicts a bad prognosis in high risk hepatoblastoma – treatment results of two consecutive trials: SIOPEL 2 and SIOPEL 3, Pediatr Blood Canc, 45, 404 Van Tornout, 1997, Timing and magnitude of decline in alpha-fetoprotein levels in treated children with unresectable or metastatic hepatoblastoma are predictors of outcome: a report from the Children’s Cancer Group, J Clin Oncol, 15, 1190, 10.1200/JCO.1997.15.3.1190 von Schweinitz, 2000, Identification of risk groups in hepatoblastoma--another step in optimising therapy, Eur J Canc, 36, 1343, 10.1016/S0959-8049(00)00138-6 von Schweinitz, 2006, Management of liver tumors in childhood, Semin Pediatr Surg, 15, 17, 10.1053/j.sempedsurg.2005.11.004 Aronson, 2005, Predictive value of the pretreatment extent of disease system in hepatoblastoma: results from the international society of pediatric oncology liver tumor study group SIOPEL-1 study, J Clin Oncol, 23, 1245, 10.1200/JCO.2005.07.145 Meyers, 2009, Predictive power of pretreatment prognostic factors in children with hepatoblastoma: a report from the Children’s Oncology Group, Pediatr Blood Canc, 53, 1016, 10.1002/pbc.22088 Dicken, 2004, Association between surgical margins and long-term outcome in advanced hepatoblastoma, J Pediatr Surg, 39, 721, 10.1016/j.jpedsurg.2004.01.035 Tiao, 2005, The current management of hepatoblastoma: a combination of chemotherapy, conventional resection, and liver transplantation, J Pediatr, 146, 204, 10.1016/j.jpeds.2004.09.011 Towu, 2004, Outcome and complications after resection of hepatoblastoma, J Pediatr Surg, 39, 199, 10.1016/j.jpedsurg.2003.10.013 Czauderna, 2005, Guidelines for surgical treatment of hepatoblastoma in the modern era--recommendations from the childhood liver tumour strategy group of the international society of paediatric oncology (SIOPEL), Eur J Canc, 41, 1031, 10.1016/j.ejca.2005.02.004 Otte, 2004, Liver transplantation for hepatoblastoma: results from the International Society of Pediatric Oncology (SIOP) study SIOPEL-1 and review of the world experience, Pediatr Blood Canc, 42, 74, 10.1002/pbc.10376 Schnater, 2002, Surgical view of the treatment of patients with hepatoblastoma: results from the first prospective trial of the international society of pediatric oncology liver tumor study group, Cancer, 94, 1111, 10.1002/cncr.10282 Meyers, 2017, Risk-stratified staging in paediatric hepatoblastoma: a unified analysis from the Children’s Hepatic tumors International Collaboration, Lancet Oncol, 18, 122, 10.1016/S1470-2045(16)30598-8